Henry Welch
Henry Welch
Henry Welch (1902—1982)[1] was an American doctor and government official who was implicated in a major scandal involving conflicts of interest between his role as director of the Division of Antibiotics at the FDA and the financial relationships he maintained with drug manufacturers and advertisers including Pfizer through his roles as an editor of several medical journals and author of editorial articles and books on the efficacy and safety of antibiotics. Dr. Welch received over $250,000 from his editorial roles between 1953 and 1959 while he also served as the top antibiotics regulator at the FDA. These financial improprieties came to light due to a Congressional investigation led by Senator Estes Kefauver that forced Dr. Welch to resign in disgrace. The Welch incident was the first major public scandal affecting a high-ranking regulator of the FDA and caused increased public scrutiny of drug advertisements.[2]
| Henry Welch | |
|---|---|
| Born | Newbury, Massachusetts, USA |
| 💀Died | Fort Lauderdale, Florida, USA |
| 💼 Occupation | Government Regulator |
| 📆 Years active | 1939-1960 |
| 👔 Employer | Food and Drug Administration |
| Known for | Conflict of Interest Scandal |
Early Life
Henry Welch was born in Newbury, Massachusetts. He received an undergraduate and a master's degree from Brown University and a PhD in bacteriology from Western Reserve University.
Career, Scandal, and Kefauver Investigation
Dr. Welch joined the FDA in 1938 where he was responsible for enacting policies that ramped up penicillin production for use by the military in World War II. Dr. Welch became the Director of the Division of Penicillin Control and Immunology at the FDA which eventually turned into the Division of Antibiotics in 1951. Dr. Welch would continue to serve as Director of the Division of Antibiotics until he was forced to resign in 1960.[2]
Pfizer was implicated in a particularly egregious incident whereby Dr. Welch’s allowed Pfizer's advertisement staff to edit a speech Dr. Welch delivered to the 1956 Antibiotics Symposium. Phrases from that speech that were inserted by Pfizer were later used for advertising material and to lend credibility to Pfizer's new antibiotics. In return, Pfizer purchased hundreds of thousands of reprints of the speech which effectively constituted a bribe to Dr. Welch of more than $85,000.[3]
In May 1960, the Chair of the Senate Antitrust and Monopoly Committee, Estes Kefauver, began a series of investigations and hearings that uncovered Dr. Welch's conflicts of interests and led Dr. Welch to resign on May 19, 1960.[4] The Welch scandal heightened attention to the lack of regulations on the marketing of new pharmaceuticals which contributed to the passage of the 1962 Kefauver-Harris Amendment that tightened regulations on drug advertisements and on the introduction of new drugs.[2]
References
- ↑ "Henry Welch, FDA Ex-Official, Dies". The Washington Post. October 29, 1982.
- ↑ 2.0 2.1 2.2 McFADYEN, RICHARD E. (1979). "THE FDA's REGULATION AND CONTROL OF ANTIBIOTICS IN THE 1950s: THE HENRY WELCH SCANDAL, FÉLIX MARTÍ-IBÁÑEZ, AND CHARLES PFIZER & CO". Bulletin of the History of Medicine. 53 (2): 159–169. ISSN 0007-5140. JSTOR 44450535. PMID 389316.
- ↑ Rosen, William (2018). "https://doctorlib.info/pharmacology/creation-antibiotics/9.html". Miracle cure: the creation of antibiotics and the birth of modern medicine. Penguin Books. ISBN 9780143110538. External link in
|chapter=(help) Search this book on
- ↑ "DRUG AIDE QUITS; BLAMES POLITICS". New York Times. May 20, 1960.
This article "Henry Welch" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Henry Welch. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
